Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

Shomali, Navid; Baradaran, Behzad; Daei Sorkhabi, Amin; Sarkesh, Aila; Kahrizi, Mohammad Saeed; Tosan, Foad; Mahmoodpoor, Ata; Mardi, Amirhossein; Mohammadi, Hamed; Hassanzadeh, Ali; Saeedi, Hossein; Hajialilo, Mehrzad; Hemmatzadeh, Maryam; Marofi, Faroogh; Sandoghchian Shotorbani, Siamak

Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

journal contribution

posted on 2024-08-15, 23:38 authored by Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi, Aila Sarkesh, Mohammad Saeed Kahrizi, Foad Tosan, Ata Mahmoodpoor, Amirhossein Mardi, Hamed Mohammadi, Ali Hassanzadeh, Hossein Saeedi, Mehrzad Hajialilo, Maryam Hemmatzadeh, Faroogh Marofi, Siamak Sandoghchian Shotorbani

Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.gene.2022.146829

Location

Amsterdam, The Netherlands

Language

en

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/35995118

Publication classification

C1.1 Refereed article in a scholarly journal

Journal

Gene

Volume

844

Article number

146829

Pagination

1-9

ISSN

0378-1119

eISSN

1879-0038

Publisher

Elsevier

Publication URL

http://dx.doi.org/10.1016/j.gene.2022.146829

Usage metrics

Keywords

ankylosing spondylitis Survivin Caspase 9 miRNA Autoreactive T cells Apoptosis

Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

History

Related Materials

Location

Language

Author URL

Publication classification

Journal

Volume

Article number

Pagination

ISSN

eISSN

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports